Meadow Creek Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Meadow Creek Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$5K	Buy	+476	New	+$5.84K	﹤0.01%	1362

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Meadow Creek Investment Management's MIRM Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2019: 476 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1362 among its holdings.

39 funds tracked by Wall St. Rank hold MIRM as of Q3 2019.

Meadow Creek Investment Management held 476 shares of Mirum Pharmaceuticals worth $5K as of Q3 2019.
Mirum Pharmaceuticals was a new Meadow Creek Investment Management position in Q3 2019.
Mirum Pharmaceuticals made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1362 holding.
39 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.